PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19
NHS hepatitis C antibody testing guidance for community pharmacy
Summarised information on offering HCV antibody testing in community pharmacy
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
COVID-19 rapid guideline on dermatological conditions
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
NICE COVID-19 management
Summary of NICE guidance on the management of COVID-19 in children, young people, and adults in primary care settings
NICE CKS on infective conjunctivitis
A summary of guidance to assist community pharmacy teams with the diagnosis and management of infective conjunctivitis
NICE CKS on chickenpox
Management of chickenpox in healthy children and adults, during pregnancy and breastfeeding, and in people who are immunocompromised
NICE CKS on common cold
A useful summary for community pharmacists covering diagnosis, management, and prescribing information in adults, children, and young people
PHE COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
Resource hub
PHE COVID-19 infection prevention and control guidance
NHS hepatitis C antibody testing guidance for community pharmacy
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
COVID-19 rapid guideline on dermatological conditions
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
NICE COVID-19 management
New advice on AstraZeneca COVID-19 vaccine issued following rare blood clot link
NICE CKS on infective conjunctivitis
PHE SARS-CoV-2 reinfection guideline
APPROPRIATE FEVER RELIEF FOR CHILDREN
- Previous
- Next
Educational resources
APPROPRIATE FEVER RELIEF FOR CHILDREN
This concise consultation card was developed by Guidelines for Pharmacy in partnership with RB UK.
Essential information and adverse reporting details are included.
RB-M-30635 February 2021